Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Noile-Immune Biotech, First Half Ordinary Profit Loss Narrows, Apr-Jun Ordinary Profit Loss Narrows
Noile-Immune Biotech, Jan-Mar (1Q) Ordinary Profit Loss Narrows
Noile-Immune Biotech, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.
Noile-Immune Biotech Inc., The Current Fiscal Year's Undisclosed Net Income to Narrow